Advertisement

Topics

ProAxsis Company Profile

23:20 EDT 18th June 2019 | BioPortfolio


News Articles [3 Associated News Articles listed on BioPortfolio]

NetScientific rockets as ProAxsis sees positive early trial data for NEATstik lung disease test

The data, published in the peer-reviewed European Respiratory Journal, found that NEATstik was able to replicate the results of existing tests for chest infections within only ten minutes

ProAxsis Ltd Product Pipeline Analysis, 2018 Update [Report Updated: 06122018] Prices from USD $750

SummaryProAxsis Ltd ProAxsis, formerly ProAxSis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The compan...

ProAxsis Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryProAxsis Ltd ProAxsis, formerly ProAxSis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The compan...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "ProAxsis" on BioPortfolio

We have published hundreds of ProAxsis news stories on BioPortfolio along with dozens of ProAxsis Clinical Trials and PubMed Articles about ProAxsis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ProAxsis Companies in our database. You can also find out about relevant ProAxsis Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record